PSYCHIATRIC DIAGNOSTIC CLARITY INVESTIGATIONS: PSYCHIATRIC MANAGEMENT AROUND GENETICS -

BY PROFESSOR DR KATY WIN, NEWA [WEDNESDAY 16TH OCTOBER 2024, 21:14] UPLOADED MONDAY 4TH NOVEMBER 09:35

Genetic Tests To Prove/Disprove a Psychiatric Severe Mental Health Disorder/Innate Learning Difficulties.

I researched in Early 2022, whether Severe Mental Health Disorders could be diagnosed Genetically. At that time Queen Mary's University London Researchers confirmed that Schizophrenia could be tested for genetically but the tests were not open to the public.

Chronic Neuroinflammation is found in disorders such as Schizophrenia, research conducted by King's Institute of Psychiatry confirmed in their Brain and Behaviour Studies conducting trials in the efficacy of Immunosuppressants and Anti-Inflammatory Agents in Treating such Severe Mental Health Disorders. It appears that Primary Immunosuppression features in such conditions. Based on this, I researched Genetic Conditions that feature dual Immunosuppression and Disorders such as all Psychotic Syndromes eg. Schizophrenia, Bipolar Disorder, Personality Disorders, Schizoaffective Disorder, ASD and ADHD Spectral Disorders and Learning Disorders such as Dyspraxia. Such conditions are all found on the c11q22 genetic loci, all of which are found in DiGeorge Syndrome.

Therefore, it is possible and seems feasible that the presence of these Mental Health Disorders and Learning Difficulties can be tested for by conducting a genetic test for the entire c11q22

Karyotype Sequence in DiGeorge Syndrome. Negative Results should confirm that such Disorders are not present in individuals where Psychiatric Diagnostic Clarity is required. It should be noted that presence of such conditions do not necessarily correspond to a diagnosis of DiGeorge Syndrome, rather that they are all linked to a specific genetic sequence, loci of c11q22. If the DiGeorge test for the entire c11q22 sequence is NEGATIVE, this indicates that the presence of these conditions is NOT INNATE, but have developed at any part of One's Lifetime from birth, and are triggered by EPIGENETIC FACTORS ie. Environmental Factors/Triggers, which Elimination of such environmental factors/triggers can lead to complete remission, even cure of such syndromes. These triggers will be personal to each individual. Such individuals with Psychiatric diagnoses also have the diagnostic propensity to develop into other related psychiatric conditions in the same spectrum.

You can find out more about this in this article:

https://my.clevelandclinic.org/health/diseases/21182-digeorge-syndrome

To test for the presence of this specific genetic loci c11q22 to assist diagnostic clarity for all Psychotic Syndromes eg. Schizophrenia, Bipolar Disorder, Personality Disorders, Schizoaffective Disorder, ASD/ ADHD Spectral Disorders and Learning Disorders such as Dyspraxia, One can collaboratively test for this in a Genetic Test for DiGeorge Syndrome to rule in/out.

THE DOCTORS LABORATORY, LONDON UK OFFER A DiGEORGE TEST BUT DO NOT OFFER TESTS ONSITE. TESTS CAN BE INSTRUCTED VIA YOUR OWN CHOSEN PHYSICIAN BY OBTAINING THE RELEVANT TEST FORMS FROM THEM.

https://www.tdlpathology.com/

ALTERNATIVELY, THIS TEST IS AVAILABLE AT THE MEDICAL EXPRESS CLINIC, HARLEY STREET, LONDON UK, WHO ANALYSE THESE TESTS VIA THE DOCTORS LABORATORY, HARLEY STREET, LONDON UK.

https://www.medicalexpressclinic.co.uk

Genetic Tests to assist Psychiatric Pharmacological Management:

To determine and guide the most optimal Psychiatric Medication Regimes, particularly in cases of poor response/ treatment resistance, The Myogenes Psychiatric Pharmacogenetics Test is the most accurate and ideal genetic test to ascertain out of all Psychiatric medications: which will give individuals the best optimal outcome; which are the most toxic; and which are the most bioavailable; also deciphering which have the most addictive potential - all based on each individual's genetic makeup. This is the most optimal route to tailor Psychiatric Medication Regimens to each Psychiatric Patient Rapidly.

Interestingly, Myogenes Report that SSRI's have no genetic benefit in Caucasians and should be avoided completely.

https://www.myogenes.com/

PROFESSOR DR KATY WIN

NEWA

UPLOADED MONDAY 4TH NOVEMBER 2024 09:35

Updated Thursday 12th December 2024 07:25